Andrea Ellis, Director of BridgeBio Pharma BBIO, has filed 0 purchases and 4 sales on the open market. Over the past 12 months that comes to a net sale of $4.2M. The latest trade was on 06/22.

AE

AE

Andrea Ellis

Director

Company

BridgeBio Pharma BBIO

First filing

23/06/23

Trades

18 trades

Buys / sales

0 / 4

12-month net buying

−$4.2M

Last trade

06/22

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
BridgeBio PharmaBBIO	Open-market sale10b5-1 plan	03/04	03/06	64,921 sh	$64.87	$4,211,425.27	−77.7%
BridgeBio PharmaBBIO	Open-market sale10b5-1 plan	25/08/05	25/08/07	17,167 sh	$49.00	$841,183	−48.0%
BridgeBio PharmaBBIO	Open-market sale10b5-1 plan	25/04/14	25/04/16	10,000 sh	$35.00	$350,000	−45.5%
BridgeBio PharmaBBIO	Open-market sale10b5-1 plan	25/04/01	25/04/03	30,000 sh	$34.05	$1,021,500	−71.4%